Mutya Harsch - Net Worth and Insider Trading
Mutya Harsch Net Worth
The estimated net worth of Mutya Harsch is at least $222,414 dollars as of 2024-11-29. Mutya Harsch is the CLO and General Counsel of Foamix Pharmaceuticals Ltd and owns about 51,969 shares of Foamix Pharmaceuticals Ltd (FOMX) stock worth over $155,387. Mutya Harsch is also the Chief Legal Officer and GC of VYNE Therapeutics Inc and owns about 22,721 shares of VYNE Therapeutics Inc (VYNE) stock worth over $67,027. Details can be seen in Mutya Harsch's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mutya Harsch has not made any transactions after 2023-03-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mutya Harsch
Mutya Harsch Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mutya Harsch owns 3 companies in total, including VYNE Therapeutics Inc (VYNE) , Foamix Pharmaceuticals Ltd (FOMX) , and Satsuma Pharmaceuticals Inc (STSA) .
Click here to see the complete history of Mutya Harsch’s form 4 insider trades.
Insider Ownership Summary of Mutya Harsch
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VYNE | VYNE Therapeutics Inc | 2023-03-20 | Chief Legal Officer and GC |
| FOMX | Foamix Pharmaceuticals Ltd | 2020-03-09 | CLO and General Counsel |
| STSA | Satsuma Pharmaceuticals Inc | 2023-06-08 | director |
Mutya Harsch Latest Holdings Summary
Mutya Harsch currently owns a total of 2 stocks. Among these stocks, Mutya Harsch owns 51,969 shares of Foamix Pharmaceuticals Ltd (FOMX) as of July 1, 2019, with a value of $155,387 and a weighting of 69.86%. Mutya Harsch also owns 22,721 shares of VYNE Therapeutics Inc (VYNE) as of March 20, 2023, with a value of $67,027 and a weighting of 30.14%.
Latest Holdings of Mutya Harsch
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FOMX | Foamix Pharmaceuticals Ltd | 2019-07-01 | 51,969 | 2.99 | 155,387 |
| VYNE | VYNE Therapeutics Inc | 2023-03-20 | 22,721 | 2.95 | 67,027 |
Holding Weightings of Mutya Harsch
Mutya Harsch Form 4 Trading Tracker
According to the SEC Form 4 filings, Mutya Harsch has made a total of 0 transactions in Foamix Pharmaceuticals Ltd (FOMX) over the past 5 years. The most-recent trade in Foamix Pharmaceuticals Ltd is the sale of 639 shares on July 1, 2019, which brought Mutya Harsch around $1,502.
According to the SEC Form 4 filings, Mutya Harsch has made a total of 1 transactions in VYNE Therapeutics Inc (VYNE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in VYNE Therapeutics Inc is the acquisition of 10,000 shares on March 20, 2023, which cost Mutya Harsch around $25,000.
Insider Trading History of Mutya Harsch
- 1
Mutya Harsch Trading Performance
GuruFocus tracks the stock performance after each of Mutya Harsch's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mutya Harsch is 96.47%. GuruFocus also compares Mutya Harsch's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mutya Harsch within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mutya Harsch's insider trading performs compared to the benchmark.
Performance of Mutya Harsch
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 71.76 | | | | | |
| Relative Return to S&P 500(%) | 67.25 | | | | | |
Mutya Harsch Ownership Network
Mutya Harsch Owned Company Details
What does VYNE Therapeutics Inc do?
Who are the key executives at VYNE Therapeutics Inc?
Mutya Harsch is the Chief Legal Officer and GC of VYNE Therapeutics Inc. Other key executives at VYNE Therapeutics Inc include 10 percent owner Perceptive Life Sciences Master Fund Ltd , Interim CFO Tyler Zeronda , and Chief Financial Officer Andrew Saik .
VYNE Therapeutics Inc (VYNE) Insider Trades Summary
Over the past 18 months, Mutya Harsch made no insider transaction in VYNE Therapeutics Inc (VYNE). Other recent insider transactions involving VYNE Therapeutics Inc (VYNE) include a net purchase of 13,000 shares made by Patrick G Lepore ,
In summary, during the past 3 months, insiders sold 0 shares of VYNE Therapeutics Inc (VYNE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of VYNE Therapeutics Inc (VYNE) were sold and 13,000 shares were bought by its insiders, resulting in a net purchase of 13,000 shares.
VYNE Therapeutics Inc (VYNE)'s detailed insider trading history can be found in Insider Trading Tracker table.
VYNE Therapeutics Inc Insider Transactions
Mutya Harsch Mailing Address
Above is the net worth, insider trading, and ownership report for Mutya Harsch. You might contact Mutya Harsch via mailing address: C/o Foamix Pharmaceuticals Ltd., 2 Holzman Street, Weizmann Science Park, Rehovot L3 76704.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
